DeepTrace Technologies

DeepTrace Technologies offers AI-powered medical devices for early-stage dementia risk assessment. Its TRACE4AD™ product analyzes brain MRI studies to identify features associated with Alzheimer's disease and mild cognitive impairment.

Claim this tool

No Views Yet

At a glance

Pricing

—

Free tier

API

—

Skill level

Technical

About

What is DeepTrace Technologies?

DeepTrace Technologies specializes in AI-powered medical devices designed to assist in the early detection and risk assessment of neurological conditions. Their flagship product, TRACE4AD™, is a CE-cleared device that provides a crucial early-stage risk assessment for dementia within a 24-month timeframe. This innovative tool works by analyzing brain MRI studies, specifically looking for features of brain atrophy that are commonly associated with Alzheimer's disease and mild cognitive impairment. It aims to offer healthcare professionals a valuable resource for proactive patient management.

Best used for

Early-stage risk assessment of dementia and mild cognitive impairment using brain MRI analysis.

Common actions

Assess dementia risk

Analyze medical images

Aid in diagnosis

Improve patient outcomes

Utilize AI in healthcare

Capabilities

Key features

AI-powered medical devices
Early dementia risk assessment
Analyzes brain MRI
Detects brain atrophy
CE-cleared

Target Audience

NeurologistsRadiologistsMedical professionalsHealthcare providers

Integrations

Not yet documented

Pricing & Plans

unknown

Not publicly disclosed. Check deeptracetech.com for current pricing.

FAQs

Is TRACE4AD™ available for direct patient use, or is it exclusively for healthcare professionals?

TRACE4AD™ is a medical device intended for use by healthcare professionals. It analyzes brain MRI studies to assist clinicians in early dementia risk assessment and is not designed for direct patient interaction or self-diagnosis.

What specific types of brain MRI studies are compatible with TRACE4AD™ for analysis?

TRACE4AD™ is designed to analyze standard brain MRI studies, specifically focusing on identifying features of brain atrophy. Healthcare providers should ensure the MRI protocols used are suitable for detailed volumetric analysis as required by the device.

How does TRACE4AD™ differentiate between normal age-related brain changes and atrophy indicative of dementia risk?

TRACE4AD™ utilizes advanced AI algorithms trained on extensive datasets to identify subtle patterns of brain atrophy that are statistically associated with an increased risk of Alzheimer's disease and mild cognitive impairment, distinguishing them from typical age-related changes.

Trending

Subcategories trending in Wellness & Lifestyle

Health & Fitness Gaming & Entertainment Mental Wellness Self-Improvement Medical & Symptom Checking Home & Real Estate

Trending

Explore

Browse AI tools by category

Content & Design Productivity & Business Coding & Development AI Agents & Automation Research & Education Wellness & Lifestyle Career Development Marketing & Growth Data & Analytics Customer Support & CX Finance E-commerce